BRPI1005979A2 - derivados de rifamicina - Google Patents

derivados de rifamicina

Info

Publication number
BRPI1005979A2
BRPI1005979A2 BRPI1005979A BRPI1005979A BRPI1005979A2 BR PI1005979 A2 BRPI1005979 A2 BR PI1005979A2 BR PI1005979 A BRPI1005979 A BR PI1005979A BR PI1005979 A BRPI1005979 A BR PI1005979A BR PI1005979 A2 BRPI1005979 A2 BR PI1005979A2
Authority
BR
Brazil
Prior art keywords
water
drilling fluid
based drilling
calcium phosphate
xyloglucans
Prior art date
Application number
BRPI1005979A
Other languages
English (en)
Inventor
Giuseppe Claudio Viscomi
Goffredo Rosini
Mahena Folegatti
Manuela Campana
Paolo Righi
Vicenzo Cannata
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of BRPI1005979A2 publication Critical patent/BRPI1005979A2/pt
Publication of BRPI1005979A8 publication Critical patent/BRPI1005979A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/20—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)

Abstract

fluido de perfuração à base de água para poços com trecho horizontal. a invenção diz respeito a um fluido de perfuração base água contendo xiloglucanas ou fosfato de cálcio, que visa prover um fluido de perfuração base água que apresente comportamento reológico satisfatório, vantagens operacionais e baixo custo de mercado por intermédio da substituição parcial da xantana por xiloglucanas ou pela substituição total do mármore micronizado pelo fosfato de cálcio.
BRPI1005979A 2009-04-20 2010-03-18 Derivados de rifamicina BRPI1005979A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI2009A000653A IT1397617B1 (it) 2009-04-20 2009-04-20 Nuovi derivati della rifamicina
PCT/IB2010/051183 WO2010122436A1 (en) 2009-04-20 2010-03-18 Rifamycin derivatives

Publications (2)

Publication Number Publication Date
BRPI1005979A2 true BRPI1005979A2 (pt) 2016-02-10
BRPI1005979A8 BRPI1005979A8 (pt) 2017-12-26

Family

ID=41228810

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1005979A BRPI1005979A8 (pt) 2009-04-20 2010-03-18 Derivados de rifamicina

Country Status (27)

Country Link
US (2) US8318763B2 (pt)
EP (1) EP2421869B1 (pt)
JP (1) JP5661100B2 (pt)
KR (1) KR101555860B1 (pt)
CN (1) CN102405223A (pt)
AR (1) AR076340A1 (pt)
AU (1) AU2010240638B2 (pt)
BR (1) BRPI1005979A8 (pt)
CA (1) CA2743801C (pt)
CL (1) CL2011002597A1 (pt)
CO (1) CO6362013A2 (pt)
DK (1) DK2421869T3 (pt)
EA (1) EA020201B1 (pt)
ES (1) ES2535327T3 (pt)
HR (1) HRP20110437A2 (pt)
IL (1) IL212942A (pt)
IT (1) IT1397617B1 (pt)
MA (1) MA33320B1 (pt)
MX (1) MX338334B (pt)
NZ (1) NZ595884A (pt)
PL (1) PL2421869T3 (pt)
PT (1) PT2421869E (pt)
SG (1) SG171989A1 (pt)
TN (1) TN2011000265A1 (pt)
TW (1) TWI422372B (pt)
UA (1) UA105775C2 (pt)
WO (1) WO2010122436A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1698630E (pt) 2005-03-03 2014-09-15 Alfa Wassermann Spa Novas formas polimorfas de rifaximina, processos para a sua produção e a sua utilização nas preparações medicinais
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
CA2886264A1 (en) * 2012-09-12 2014-03-20 Salix Pharmaceuticals, Inc. Methods of administering rifaximin without producing antibiotic resistance
CN103709177B (zh) * 2013-12-20 2016-02-24 武汉工程大学 利福霉素类沃尼妙林杂合抗生素及其制备方法
KR102362719B1 (ko) * 2014-05-12 2022-02-14 알파시그마 에스.피.에이. 리팍시민의 신규한 용매화 결정 형태, 생산물, 조성물 및 이의 용도
CN110770244A (zh) * 2017-06-26 2020-02-07 倍尔福股份公司 吡啶并咪唑利福霉素衍生物的抗菌剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH547854A (de) * 1969-05-30 1974-04-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von antibiotika.
SU465795A3 (ru) * 1972-05-05 1975-03-30 Группо Лепетит (Фирма) Способ получени рифамицина в.
CH571064A5 (en) * 1973-03-01 1975-12-31 Archifar Ind Chim Trentino Recovery of rieamycin from broths - by oxidn to an insol form
US3847903A (en) * 1973-03-01 1974-11-12 Archifar Ind Chim Trentino Method for extracting and isolating rifamycin o from fermentation broths of rifamycins
US4267274A (en) * 1973-04-26 1981-05-12 Gruppo Lepetit S.P.A. Streptomyces mediterranei mutant capable of production of rifamycin B
GB1470426A (en) * 1974-08-30 1977-04-14 Lepetit Spa Rifamycins
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1199374B (it) * 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
US7923553B2 (en) * 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e

Also Published As

Publication number Publication date
WO2010122436A1 (en) 2010-10-28
NZ595884A (en) 2012-12-21
US20100267654A1 (en) 2010-10-21
CA2743801C (en) 2017-03-07
CA2743801A1 (en) 2010-10-28
KR101555860B1 (ko) 2015-09-25
TWI422372B (zh) 2014-01-11
TW201039819A (en) 2010-11-16
UA105775C2 (uk) 2014-06-25
MX338334B (es) 2016-04-11
CL2011002597A1 (es) 2012-03-23
IL212942A0 (en) 2011-07-31
JP5661100B2 (ja) 2015-01-28
AU2010240638B2 (en) 2014-06-05
PL2421869T3 (pl) 2015-08-31
ITMI20090653A1 (it) 2010-10-21
CN102405223A (zh) 2012-04-04
EA201190216A1 (ru) 2012-02-28
CO6362013A2 (es) 2012-01-20
EA020201B1 (ru) 2014-09-30
SG171989A1 (en) 2011-07-28
BRPI1005979A8 (pt) 2017-12-26
JP2012524060A (ja) 2012-10-11
IL212942A (en) 2015-06-30
TN2011000265A1 (en) 2012-12-17
DK2421869T3 (da) 2015-06-08
EP2421869A1 (en) 2012-02-29
KR20120014110A (ko) 2012-02-16
PT2421869E (pt) 2015-04-29
HK1163663A1 (en) 2012-09-14
AR076340A1 (es) 2011-06-01
HRP20110437A2 (hr) 2011-09-30
ES2535327T3 (es) 2015-05-08
MA33320B1 (fr) 2012-06-01
US20130287692A1 (en) 2013-10-31
MX2011011026A (es) 2011-11-02
IT1397617B1 (it) 2013-01-18
US8318763B2 (en) 2012-11-27
EP2421869B1 (en) 2015-03-11
AU2010240638A1 (en) 2010-10-28
US8765778B2 (en) 2014-07-01

Similar Documents

Publication Publication Date Title
BRPI1005979A2 (pt) derivados de rifamicina
PA8846901A1 (es) Inhibidores de cinasa akt y p70 s6.
EA201200409A1 (ru) Составы и способы для обслуживания скважин
CO6311114A2 (es) Método para recuperación asistida del petroleo de una formación subterranea por medio de una composición viscoelástica con estabilidad mejorada
AR061870A1 (es) Aditivo para perdida de fluidos para barros de petroleo
MY140119A (en) Drilling fluids
BR112015031288A2 (pt) fluido de trabalho para ciclo térmico, composição para sistema de ciclo térmico e sistema de ciclo térmico
GB201316784D0 (en) Graphene-containing fluids for oil and gas exploration and production
BRPI0812769A2 (pt) Aditivo para reduzir perda de fluido para fluidos de perfuração .
BR112013024918A2 (pt) sistema de fluido de alta pressão - alta temperatura livre de sólidos para perfuração, terminação e reparação de poços de petróleo e gás
EA201291443A1 (ru) Скважинный флюид с постоянной реологией
BR112012030703B8 (pt) válvula gaveta, método para controle de pressão de lama de perfuração retornada e/ou extinção de poço e uso de uma válvula gaveta
NO20092857L (no) Vannbasert borefluid
BR112012024323A2 (pt) ferramenta de fundo de poço e método
BR112012018838A2 (pt) método e disposição para lubrificar haste de broca de máquina de perfuração de rocha
BR112012013783A2 (pt) processo para estabilizar uma preparação mineral aquosa, preparação aquosa, e, usos de pelo menos um alcanol amina primária de monoálcool e da preparação aquosa.
MX270311B (es) Fluido de perforacion que comprende hidrofobina.
EA201391779A1 (ru) Способы модификации буровых растворов для улучшения ликвидации поглощения бурового раствора
BRPI0812022A2 (pt) Composições para produção de soja com teor de óleo elevado.
BR112015028299A8 (pt) Formulação inibitória de corrosão, uso de pelo menos um composto compreendendo pelo menos um radical triazina, e uso de uma formulação inibitória de corrosão
BR112012006574A2 (pt) mistura-mestre para a produção de um fluido de perfuração
BRPI0418995A (pt) método para a inibição hidratação de argilas nas operações de perfuração, e, fluido de perfuração com base aquosa
BR112015014186A2 (pt) conjunto para produção de uma ligação tubular roscada resistente à gripagem
BR112017014093A2 (pt) composições inibidoras de hidrato de gás de baixa dose
BR112015000211A2 (pt) junta de segurança e coluna de ferramentas

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B25A Requested transfer of rights approved

Owner name: ALFASIGMA S.P.A. (IT)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]